Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 131

1.

The Role of Pharmacists and Pharmacy Education in Point-of-Care Testing.

Kehrer JP, James DE.

Am J Pharm Educ. 2016 Oct 25;80(8):129.

2.

Free radicals and related reactive species as mediators of tissue injury and disease: implications for Health.

Kehrer JP, Klotz LO.

Crit Rev Toxicol. 2015;45(9):765-98. doi: 10.3109/10408444.2015.1074159. Epub 2015 Sep 7. Review.

PMID:
26610815
3.

More Information about Postbaccalaureate PharmD Training.

Breault R, Hall J, Kehrer JP.

Can J Hosp Pharm. 2014 Nov;67(6):460. No abstract available.

4.

Pharmacy's role in a modern health continuum.

Kehrer JP, Eberhart G, Wing M, Horon K.

Can Pharm J (Ott). 2013 Nov;146(6):321-4. doi: 10.1177/1715163513506370. No abstract available.

5.

Scientifically unfounded precaution drives European Commission's recommendations on EDC regulation, while defying common sense, well-established science and risk assessment principles.

Dekant W, Kehrer JP.

Toxicol Lett. 2013 Nov 25;223(2):A1-4. doi: 10.1016/j.toxlet.2013.07.010. Epub 2013 Jul 31. No abstract available.

PMID:
23916789
6.

Advancing pharmacist scholarship and research within academic pharmacy.

Kehrer JP, Svensson CK.

Am J Pharm Educ. 2012 Dec 12;76(10):187. doi: 10.5688/ajpe7610187.

7.

University-based continuing education for pharmacists.

Schindel TJ, Kehrer JP, Yuksel N, Hughes CA.

Am J Pharm Educ. 2012 Mar 12;76(2):20. doi: 10.5688/ajpe76220.

8.

Cooperation in pharmacy education in Canada and the United States.

Kehrer JP, Schindel TJ, Mann HJ.

Am J Pharm Educ. 2010 Oct 11;74(8):142.

9.

Report of the 2008-2009 Standing Committee on Advocacy.

Kehrer JP, Brazeau GA, DeGuire N, Dopp AL, Orrico KB, Marchand HC, Lang WG.

Am J Pharm Educ. 2009;73 Suppl:S8. No abstract available.

10.

Lipocalin-2: pro- or anti-apoptotic?

Kehrer JP.

Cell Biol Toxicol. 2010 Apr;26(2):83-9. doi: 10.1007/s10565-009-9119-9. Epub 2009 Jan 22. Review.

PMID:
19160065
11.

Factors influencing the pharmacy faculty workforce.

Beardsley R, Matzke GR, Rospond R, Williams J, Knapp K, Kradjan W, Kehrer JP, Zavod R, Davis P, Brazeau D.

Am J Pharm Educ. 2008 Apr 15;72(2):34.

12.

New pharmacy faculty enculturation to facilitate the integration of pharmacy disciplines and faculty retention.

Kehrer JP, Kradjan W, Beardsley R, Zavod R.

Am J Pharm Educ. 2008 Feb 15;72(1):18. No abstract available.

13.

Thioredoxin-related mechanisms in hyperoxic lung injury in mice.

Tipple TE, Welty SE, Rogers LK, Hansen TN, Choi YE, Kehrer JP, Smith CV.

Am J Respir Cell Mol Biol. 2007 Oct;37(4):405-13. Epub 2007 Jun 15.

14.

Mechanisms of N-acetylcysteine-driven enhancement of MK886-induced apoptosis.

Deshpande VS, Kehrer JP.

Cell Biol Toxicol. 2006 Jul;22(4):303-11. Epub 2006 Jun 30.

PMID:
16817014
15.

Cytotoxicity of a non-cyclooxygenase-2 inhibitory derivative of celecoxib in non-small-cell lung cancer A549 cells.

Tong Z, Wu X, Chen CS, Kehrer JP.

Lung Cancer. 2006 Apr;52(1):117-24. Epub 2006 Feb 23.

PMID:
16497409
16.

Oxidative stress-driven mechanisms of nordihydroguaiaretic acid-induced apoptosis in FL5.12 cells.

Deshpande VS, Kehrer JP.

Toxicol Appl Pharmacol. 2006 Aug 1;214(3):230-6. Epub 2006 Feb 10.

PMID:
16473382
17.

Neutrophil gelatinase-associated lipocalin as a survival factor.

Tong Z, Wu X, Ovcharenko D, Zhu J, Chen CS, Kehrer JP.

Biochem J. 2005 Oct 15;391(Pt 2):441-8.

18.
19.

Effect of acrolein and glutathione depleting agents on thioredoxin.

Yang X, Wu X, Choi YE, Kern JC, Kehrer JP.

Toxicology. 2004 Nov 15;204(2-3):209-18.

PMID:
15388247
20.
21.

Thioredoxin and its role in toxicology.

Watson WH, Yang X, Choi YE, Jones DP, Kehrer JP.

Toxicol Sci. 2004 Mar;78(1):3-14. Epub 2003 Dec 22. Review.

PMID:
14691207
22.

Roles of 5-lipoxygenase activating protein in cell proliferation and apoptosis.

Wu X, Biswal SS, Kehrer JP.

Cell Biol Toxicol. 2003 Jun;19(3):135-43.

PMID:
12945742
23.

Report by the editors.

Kehrer JP, Dekant W.

Toxicol Lett. 2003 Aug 28;143(3):241-5. No abstract available.

PMID:
12849684
24.

Modulation of benzo[a]pyrene-induced p53 DNA activity by acrolein.

Biswal S, Maxwell T, Rangasamy T, Kehrer JP.

Carcinogenesis. 2003 Aug;24(8):1401-6. Epub 2003 Apr 24.

PMID:
12807757
25.

Increased expression of the lipocalin 24p3 as an apoptotic mechanism for MK886.

Tong Z, Wu X, Kehrer JP.

Biochem J. 2003 May 15;372(Pt 1):203-10.

26.

Fatty acid release and oxidation are factors in lipoxygenase inhibitor-induced apoptosis.

La E, Kern JC, Atarod EB, Kehrer JP.

Toxicol Lett. 2003 Mar 3;138(3):193-203.

PMID:
12565196
27.

Inhibition of peroxisome proliferator-activated receptor (PPAR)-mediated keratinocyte differentiation by lipoxygenase inhibitors.

Thuillier P, Brash AR, Kehrer JP, Stimmel JB, Leesnitzer LM, Yang P, Newman RA, Fischer SM.

Biochem J. 2002 Sep 15;366(Pt 3):901-10.

28.

Fatty acid oxidation and signaling in apoptosis.

Tang DG, La E, Kern J, Kehrer JP.

Biol Chem. 2002 Mar-Apr;383(3-4):425-42. Review.

PMID:
12033433
29.
30.
31.

Acrolein-induced cell death: a caspase-influenced decision between apoptosis and oncosis/necrosis.

Kern JC, Kehrer JP.

Chem Biol Interact. 2002 Jan 22;139(1):79-95.

PMID:
11803030
32.

Acute exposure of cerebellar granule neurons to ethanol suppresses stress-activated protein kinase-1 and concomitantly induces AP-1.

Acquaah-Mensah GK, Leslie SW, Kehrer JP.

Toxicol Appl Pharmacol. 2001 Aug 15;175(1):10-8.

PMID:
11509022
33.

Proteolytic loss of bcl-x(L) in FL5.12 Cells undergoing apoptosis induced by MK886.

Datta K, Kern JC, Biswal SS, Kehrer JP.

Toxicol Appl Pharmacol. 2001 Aug 1;174(3):273-81.

PMID:
11485388
34.

Inhibition of peroxisome-proliferator-activated receptor (PPAR)alpha by MK886.

Kehrer JP, Biswal SS, La E, Thuillier P, Datta K, Fischer SM, Vanden Heuvel JP.

Biochem J. 2001 Jun 15;356(Pt 3):899-906.

35.
36.

Professional toxicology societies: web based resources.

Kehrer JP, Mirsalis J.

Toxicology. 2001 Jan 12;157(1-2):67-76.

PMID:
11164975
37.

Changes in ceramide and sphingomyelin following fludarabine treatment of human chronic B-cell leukemia cells.

Biswal SS, Datta K, Acquaah-Mensah GK, Kehrer JP.

Toxicology. 2000 Nov 23;154(1-3):45-53.

PMID:
11118669
38.

Cause-effect of oxidative stress and apoptosis.

Kehrer JP.

Teratology. 2000 Oct;62(4):235-6. Review. No abstract available.

PMID:
10992267
39.

The molecular effects of acrolein.

Kehrer JP, Biswal SS.

Toxicol Sci. 2000 Sep;57(1):6-15. Review.

PMID:
10966506
40.

The Haber-Weiss reaction and mechanisms of toxicity.

Kehrer JP.

Toxicology. 2000 Aug 14;149(1):43-50. Review.

PMID:
10963860
41.

Report by the editors

Kehrer JP, Dekant W.

Toxicol Lett. 2000 Jul 27;116(1-2):1-6. No abstract available.

PMID:
10906416
42.
43.

Heat-shock protein 70 antisense oligomers enhance proteasome inhibitor-induced apoptosis.

Robertson JD, Datta K, Biswal SS, Kehrer JP.

Biochem J. 1999 Dec 1;344 Pt 2:477-85.

44.
45.
46.

Acrolein causes inhibitor kappaB-independent decreases in nuclear factor kappaB activation in human lung adenocarcinoma (A549) cells.

Horton ND, Biswal SS, Corrigan LL, Bratta J, Kehrer JP.

J Biol Chem. 1999 Apr 2;274(14):9200-6.

47.

A relationship between 5-lipoxygenase-activating protein and bcl-xL expression in murine pro-B lymphocytic FL5.12 cells.

Datta K, Biswal SS, Xu J, Towndrow KM, Feng X, Kehrer JP.

J Biol Chem. 1998 Oct 23;273(43):28163-9.

48.

Vitamin E concentration in rat skeletal muscle and liver after exercise.

Swift JN Jr, Kehrer JP, Seiler KS, Starnes JW.

Int J Sport Nutr. 1998 Jun;8(2):105-12.

PMID:
9637190
49.

Mixed effects of 2,6-dithiopurine against cyclophosphamide mediated bladder and lung toxicity in mice.

Datta K, Chin A, Ahmed T, Qing WG, Powell KL, Simhambhatla P, MacLeod MC, Stoica G, Kehrer JP.

Toxicology. 1998 Jan 16;125(1):1-11.

PMID:
9585095
50.

Bcl-2 and Bcl-xL in peroxide-resistant A549 and U87MG cells.

Bojes HK, Suresh PK, Mills EM, Spitz DR, Sim JE, Kehrer JP.

Toxicol Sci. 1998 Apr;42(2):109-16.

PMID:
9579023

Supplemental Content

Loading ...
Support Center